OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions […]
Appoints Marietta Edmunds Zakas as Chief Executive Officer Promotes Current Chief Operating Officer Paul McAndrew to President Welcomes Brian Healy […]